Med Spa Injectables: Product Liability, Off-Label Use, and the Sourcing Question That Can Void Coverage

How does product sourcing affect insurance coverage?

Med spa professional liability policies increasingly contain conditions requiring that all injectable products be obtained through FDA approved channels from authorized distributors. When a patient is injured by product purchased from a gray market source, a foreign supplier, or an unverified online vendor, the carrier can deny on the basis of that condition, and the practice ends up funding the defense itself. The clinical outcome may be identical to a claim that would have been covered. The procurement path is what changes the answer.

• Many forms require product sourced from FDA approved, authorized US distribution channels
• Gray market and imported product is a common denial trigger
• Counterfeit product has appeared in the US aesthetic market and is difficult to identify visually
• Keep purchase records, lot numbers, and distributor documentation for every vial used
• Record the lot number in the patient chart at the time of treatment

What is off-label use and is it covered?

Off-label use means administering an approved product for an indication, dose, or anatomical site other than what the FDA approved. It is legal, common, and clinically appropriate in many aesthetic contexts. Coverage is a separate question. Some policies expressly cover off-label use when performed within the standard of care by an appropriately licensed provider. Others exclude it, and others are silent, which leaves the argument to be had after a claim. Practices that rely heavily on off-label techniques should confirm the position in writing before they need it.

• Off-label use is legal and common in aesthetics, including many neurotoxin and filler applications
• Coverage varies by form, from affirmative inclusion to express exclusion to silence
• Informed consent should specifically disclose off-label use and be documented per treatment
• Ask the carrier for written confirmation of the position on off-label aesthetic use
• Maintain protocols and training records supporting standard of care for each technique

What about compounded and non-FDA approved products?

Compounded products, including certain weight management peptides and custom formulations, sit in a different regulatory category and a different insurance category. Coverage frequently depends on whether the compounding pharmacy holds the right registration and whether the product is being used within permitted parameters. Practices that added compounded weight management services during the recent demand surge often did so without telling their carrier, which creates a disclosure problem on top of a coverage problem, because an undisclosed material change in operations can affect the entire policy rather than just the new service line.

• Verify the compounding pharmacy's state licensure and, where applicable, FDA outsourcing facility registration
• Confirm whether your policy covers compounded products at all, and under what conditions
• Disclose new service lines to your carrier at the time you add them, not at renewal
• Weight management, hormone therapy, and IV therapy are commonly treated as distinct exposures requiring separate underwriting
• Document medical evaluation, prescribing authority, and follow up protocols for each service

Who is liable when a product itself is defective?

When the injury is caused by the product rather than by the technique, product liability principles apply, and the manufacturer is the primary target. That only helps if the manufacturer is identifiable, solvent, and subject to US jurisdiction, which is precisely what gray market sourcing puts at risk. A med spa that cannot document a legitimate chain of custody may find itself as the only defendant standing, defending a product claim it did not create, with a professional liability policy that may or may not respond to a products allegation.

• Products liability and professional liability are different coverage grants with different triggers
• Confirm your general liability policy includes products and completed operations coverage
• Documented chain of custody preserves your ability to bring the manufacturer into the claim
• Foreign manufacturers are often practically unreachable, leaving the practice exposed
• Adverse event reporting to the manufacturer and the FDA should be part of your incident protocol

What controls protect a med spa's coverage position?

The controls here are administrative rather than clinical, which is why they are so often neglected. A purchasing policy that restricts buying to named authorized distributors, a lot tracking practice that ties every vial to a chart, and a consent process that addresses off-label use will resolve most coverage disputes before they start. None of this is expensive. All of it is the difference between a covered claim and a self funded one.

• Written purchasing policy naming approved distributors, with owner approval required for exceptions
• Lot number logged in the patient chart at every injectable treatment
• Invoices and distributor records retained for a minimum of seven years
• Treatment specific informed consent that addresses off-label use where applicable
• Annual verification of medical director oversight, delegation, and supervision records
• Written notice to the carrier before adding any new device, product category, or service line

Ready to check your med spa's coverage conditions?

Grandbay Financial Services reviews aesthetic practice programs against how the practice actually operates, including purchasing, delegation, and service mix. If you have added services in the past year, your policy probably has not caught up. Schedule a review at calendly.com/grandbayfinancial.